What is the Vanguard Urologic
The Vanguard Urologic Research Foundation is a not-for-profit research organization that provides support for clinical and translational research, with primary focus on prostate cancer, benign prostatic diseases, urinary incontinence, and urinary reconstruction using engineered tissue components, under the direction of the physicians and researchers in the Vanguard Urologic Institute.
We improve patient care by integrating clinical research
Using our state-of-the-art information technology platform, the Vanguard Urologic Institute has integrated clinical research into the daily care of our patients, while taking great care to protect sensitive, private information, according to HIPAA guidelines. Thus, after obtaining consent, all patient information is collected in an electronic format that allows seamless integration of relevant clinical information to the translational activities of the Institute.
A large bio-repository of blood, urine, and tissue samples is under continuous expansion; and the comprehensive patient, treatment, and outcome information it holds makes it a uniquely valuable resource for translational research. Our CLIA-certified clinical diagnostic and histopathology lab, located in our Clinical and Laboratory Research Facility in the UT Professional Building, just next door to our main facility in the Memorial Hermann Medical Plaza, provides onsite analysis and timely reporting of test results for research purposes and clinical care.
The experienced personnel in our clinical research unit conduct pharmaceutical-sponsored clinical trials, as well as those developed by our own investigators. They have a well-demonstrated ability to integrate research into the daily clinical care of our patients so that we are continuously improving the quality of their care and bringing leading-edge treatments and technologies to them as quickly as possible.
President: Kevin M. Slawin, M.D.
back to top